| Tap a line for its trend | Last 12Mto Dec 2025 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22Mar 2022 | FY21 and earlierAlpha Plus |
|---|
| 65.91× | 65.91× | 57.69× | 53.38× | 56.51× | FY21 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.62× | 2.39× | 2.89× | — | — | ||
| 1.79× | 1.79× | 1.96× | 2.13× | 2.02× | ||
| 0.80× | 0.80× | 0.78× | 0.93× | 0.42× | ||
| 0.29× | 0.29× | 0.25× | 0.66× | 0.30× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY22 31/03/2022 | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | Last 12M 31/12/2025 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 56.51 | 53.38 | 57.69 | 65.91 | 65.91 | |
| Working Capital Turnover | — | — | 2.89 | 2.39 | 2.62 | |
| Asset Turnover | 2.02 | 2.13 | 1.96 | 1.79 | 1.79 | |
| Cash Conversion (CFO/Net Income) | 0.42 | 0.93 | 0.78 | 0.80 | 0.80 | |
| CFO/EBITDA | 0.30 | 0.66 | 0.25 | 0.29 | 0.29 |